Here’s How the Proposed CVS-Aetna Merger Could Increase Costs, Restrict Access

Theresa Rohr-Kirchgraber, MD, President AMWA 2015 – 2016, discussed the CVS and Aetna merger and its potential adverse effects on patients.

“While the U.S. Department of Justice may not have plans to challenge the $69 billion mega-merger of CVS and Aetna, patients and physicians should do so at every turn. The acquisition of the country’s third largest insurer by the nation’s largest pharmacy benefit manager could not only increase health-care costs, but restrict access to care for millions of insured Americans…”